Telemedicine Retinal Screening Utilizing a Mobile Medical Unit

This study has been completed.
Sponsor:
Collaborators:
Fonseca Family Foundation
Blue Shield Foundation
NCRR 1U54RR025204-01-01
Information provided by:
Scripps Whittier Diabetes Institute
ClinicalTrials.gov Identifier:
NCT01412905
First received: August 8, 2011
Last updated: NA
Last verified: August 2011
History: No changes posted

August 8, 2011
August 8, 2011
February 2007
December 2008   (final data collection date for primary outcome measure)
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Telemedicine Retinal Screening Utilizing a Mobile Medical Unit
Telemedicine Retinal Screening Utilizing a Mobile Medical Unit With a Trained Technician Accurately Detects Disease in High Risk Ethnically Diverse Populations: Results of a Project Dulce™ Retinal Screening Study

Objective: To test the accuracy of a referral system for diabetic eye disease conducted by a trained screener using a digital camera, a mobile medical unit and a centralized image-storing software in underserved, ethnically diverse neighborhoods in San Diego.

Methods and Research Design: Retinal screening exams were offered at 8 community health centers for 1229 individuals, ages 16-80 years with diabetes throughout San Diego County over 18 months. Images were captured with a special digital camera, securely transferred to a software system and read independently by a trained technician and retinal specialist. An analysis was conducted to evaluate who had severe eye disease and how accurate the reading of the technician were compared to the expert ophthalmologist readings.

The investigators would like to demonstrate that telemedicine retinal screening utilizing a mobile medical unit with a trained technician in high-risk, ethnically diverse populations can accurately detect positive and negative disease. This may be a model to increase access to retinal examination in order to meet current guidelines and can allow more efficient use of the retinal specialist to evaluate and treat disease leading to a more cost efficient method of care.

Objective: To test the validity and accuracy of a grading and referral system for diabetic retinopathy conducted by a trained screener using a digital camera, a mobile medical unit and a centralized image-storing software in underserved, ethnically diverse neighborhood community health centers Methods and Research Design: Retinal screening exams using telemedicine technology were offered at 8 community health centers for 1229 individuals, ages 16-80 years with diabetes throughout San Diego County over 18 months. Images were electronically captured, transferred to EyePACs1 image software and read independently by a trained technician and retinal specialist. Statistical analysis was conducted to evaluate prevalence of disease and accuracy and validity of readings. Snellen eye test and glaucoma testing using tonometry will also be conducted.

Results: Will evaluate demographics that include age, gender, ethnicity, duration of diabetes, type of diabetes and need for dilation. Severity of disease will be captured. Statistical analysis will be conducted for technician accuracy of grading the readings.

Conclusions: To demonstrate that telemedicine retinal screening utilizing a mobile medical unit with a trained technician in high-risk, ethnically diverse populations can accurately detect positive and negative screens. This may be a model to increase access to retinal examination in order to meet ADA and HEDIS guidelines and can allow more efficient use of the retinal specialist to evaluate and treat disease leading to a more cost efficient method of care.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Men and Women, ages 16-80 with type 1 and type 2 diabetes mellitus identified from 8 community health centers in San Diego County.

  • Diabetes
  • Retinopathy
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
1229
August 2009
December 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • age 16-80 years;
  • diagnoses of type 1 or 2 diabetes;
  • enrolled in one of the participating clinics or has a personal primary care provider;
  • no or minimal insurance and is a San Diego County resident.

Exclusion criteria:

  • high intra-ocular pressure > 21 mmHg and < 4 mm of pupil dilation
  • known allergy to latex .
Both
16 Years to 80 Years
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01412905
SWDI-Retinal
Not Provided
Athena Philis-Tsimikas, MD, Scripps Whittier Diabetes Institute
Scripps Whittier Diabetes Institute
  • Fonseca Family Foundation
  • Blue Shield Foundation
  • NCRR 1U54RR025204-01-01
Principal Investigator: Athena Philis-Tsimikas, MD Scripps Whittier Diabetes Institute
Scripps Whittier Diabetes Institute
August 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP